Victor Weigman, Ph.D. | June 01, 2017

Designing AML Panel for Clinical Testing

Presentation from PMWC - Duke University, May 2017
Presented at the Precision Medicine World Conference (PMWC) at Duke University on May 24, 2017, this presentation provides an overview of designing an Acute Myeloid Leukemia Panel, including where to start, AML biomarker considerations and utilizing the back-end database. 

Download the presentation to learn more about determining the ability to hunt biomarkers based on importance of publication; driving gene association to diagnostic testing and treatment related; and supporting gene selection due to publication prevalence.

Victor Weigman, Ph.D., Director, Translational Genomics

Related Services:
Genomic Assays for Clinical Development

Identifying the right approach from a wealth of potential options

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Translating Data into Insights with Bioinformatics

Systematic Design and Development of the Q2 Solutions Comprehensive Cancer Panel

A Case Study in Iterative Design and Validation

Read More